罗欣药业: 关于控股子公司开展融资租赁业务暨担保进展的公告

Financing and Guarantee Overview - The company plans to continue financing leasing business for its subsidiaries, with a total amount not exceeding 150 million RMB, authorized for a period of 12 months from the board's approval date [1][2] - The company and its subsidiaries intend to provide guarantees totaling up to 648 million RMB for the year 2025, which includes various forms of guarantees among subsidiaries [2][3] Guarantee Progress - The company has provided irrevocable joint liability guarantees for financing leases of 20 million RMB for Shandong Luoxin and 30 million RMB for Shandong Yuxin, within the approved limits [3][8] - After the guarantees, the total guarantee balance for Shandong Luoxin will be 1,164.82 million RMB, with a remaining guarantee capacity of 797.79 million RMB [3][8] - For Shandong Yuxin, the total guarantee balance will be 30 million RMB, with a remaining guarantee capacity of 81 million RMB [3][8] Financial Data of Subsidiaries - Shandong Luoxin reported total assets of 4,972.40 million RMB and total liabilities of 2,756.94 million RMB for the year 2024, with a net profit of -632.30 million RMB [5] - Shandong Yuxin reported total assets of 909.11 million RMB and total liabilities of 635.76 million RMB for the year 2024, with a net profit of -1,160.44 million RMB [6] Board's Opinion - The board believes that engaging in financing leasing will effectively meet the company's operational funding needs and optimize the capital structure [8] - The company maintains effective control over Shandong Luoxin, ensuring manageable risk levels for the guarantees provided [8] Total Guarantee Amount - After the new guarantees, the total guarantee amount by the company and its subsidiaries will be 2,538 million RMB, representing 183.61% of the latest audited net assets [9]